Entheon Biomedical announces a three-cornered amalgamation with MPV Exploration along with concurrent financing.
Articles
Field Trip Psychedelics Inc. Launches Field Trip Basecamp for combat veterans, first responders and healthcare workers
Field Trip announces a new therapeutic program as the company prepares for its coming RTO.
Which Equities Can Best Survive Hyperinflation?
U.S. hyperinflation is coming. This is the best strategy to prepare.
Psychedelics: A Better Way To Treat Depression
Psychedelic drugs represent a potentially enormous step forward in treating an epidemic for which there are currently no good treatment options.
Virginia’s Marijuana Decriminalization Law Officially Takes Effect
A marijuana decriminalization policy is officially in effect in Virginia as of Wednesday.
New Wave Holdings Appoints Dr. Dennis McKenna to Psychedelic Research Advisory Board
New Wave Holdings Corp has added a recognized expert in psychedelic medicine to the company's Advisory Board.
Champignon Brands Announces Regulatory Review, Cease Trade Order
Trading of Champignon Brands (SHRM) on the Canadian Securities Exchange has been temporarily halted due to the failure to file necessary disclosures with respect to recent acquisitions.
GreenStar Biosciences Signs Agreement to Acquire 100% of Eleusian Biosciences Corp.
Greenstar Biosciences is entering the psychedelics space via its acquisition of Eleusian Biosciences Corp.
Oregon cannabis cultivation company leveraging partnerships, new retail presence to increase exposure, footprint
While still fairly small, East Fork Cultivars has become one of the most respected cannabis cultivators in the Pacific Northwest.
MindMed And Eleusis Lead The Way In Psychedelics Micro-Dosing Research
Given that psychedelics micro-dosing has several commercial advantages, here are two companies that investors should look at.
Mydecine Innovations Group Inc. Signs Partnership Agreement With Applied Pharmaceutical Innovation
Mydecine announces research agreement with a leading pharmacology research institution.
Eleusis Looks For Alzheimer’s Breakthrough With Micro-Dosed LSD
Eleusis Therapeutics is a private psychedelics company that is turning a lot of heads with its research on micro-doses of LSD as a treatment for Alzheimer's.
Red Light Holland Announces The Closing of Second Tranche of Private Placement
With the closing of its second tranche, Red Light Holland has now raised $3,830,529 in its current private placement.
Mydecine Innovations Inks Important Research Agreement
Mydecine's research agreement with the University of Alberta is a key stepping-stone in expediting its psilocybin-based drug development research.
North Sur Resources and Mindset Pharma Announce Proposed Transaction to Accelerate Development of Medical Psychedelics Industry
An amalgamation of two private companies as psychedelics company Mindset Pharma Inc prepares to go public.